AI-generated summary
The authors studied a narrow-band blue light system (ClearLight) in 28 adults with facial acne, given eight biweekly sessions. They report a 64.7% improvement in acne lesions, no change in bacterial detection before or after therapy, and damaged Propionibacterium acnes seen at the ultrastructural level. The authors state that further investigation is needed to explain how the light acts.
- Participants
- 28
- Who or what was studied
- Adults with facial acne (mean age 28.1 years, range 16 to 56 years)
- Limits stated in the abstract
- The abstract does not describe a control group, and only nine patients were followed after treatment, with the authors calling for further investigation of the mechanism.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 420 nm
How to read a trial: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.